CANCER:

Colorectal Adenocarcinoma

Related cancers:

‹

Colorectal Cancer (1109)

Colon Cancer (134)

Rectal Cancer (53)

Colorectal Cancer (1109)

Colon Cancer (134)

Rectal Cancer (53)

›

PIK3CA V955G PIK3CA V955G	Colorectal Adenocarcinoma Colorectal Adenocarcinoma	PIK3CA V955G PIK3CA V955G	Colorectal Adenocarcinoma Colorectal Adenocarcinoma	cetuximab Resistant: C3 – Early Trials	cetuximab Resistant: C3 – Early Trials
ALK fusion ALK fusion	Colorectal Adenocarcinoma Colorectal Adenocarcinoma	ALK fusion ALK fusion	Colorectal Adenocarcinoma Colorectal Adenocarcinoma	ceritinib Sensitive: C3 – Early Trials	ceritinib Sensitive: C3 – Early Trials
KRAS mutation KRAS mutation	Colorectal Adenocarcinoma Colorectal Adenocarcinoma	KRAS mutation KRAS mutation	Colorectal Adenocarcinoma Colorectal Adenocarcinoma	ceritinib Resistant: C3 – Early Trials	ceritinib Resistant: C3 – Early Trials
EWSR1 mutation EWSR1 mutation	Colorectal Adenocarcinoma Colorectal Adenocarcinoma	EWSR1 mutation EWSR1 mutation	Colorectal Adenocarcinoma Colorectal Adenocarcinoma	sintilimab + fruquintinib Resistant: C3 – Early Trials	sintilimab + fruquintinib Resistant: C3 – Early Trials
PD-L2 overexpression PD-L2 overexpression	Colorectal Adenocarcinoma Colorectal Adenocarcinoma	PD-L2 overexpression PD-L2 overexpression	Colorectal Adenocarcinoma Colorectal Adenocarcinoma	PD-L1 inhibitor + PD-L2 inhibitor Sensitive: D – Preclinical	PD-L1 inhibitor + PD-L2 inhibitor Sensitive: D – Preclinical
KRAS G13D KRAS G13D	Colorectal Adenocarcinoma Colorectal Adenocarcinoma	KRAS G13D KRAS G13D	Colorectal Adenocarcinoma Colorectal Adenocarcinoma	ASN007 Sensitive: D – Preclinical	ASN007 Sensitive: D – Preclinical
APC mutation APC mutation	Colorectal Adenocarcinoma Colorectal Adenocarcinoma	APC mutation APC mutation	Colorectal Adenocarcinoma Colorectal Adenocarcinoma	ST316 Sensitive: D – Preclinical	ST316 Sensitive: D – Preclinical